Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants

被引:1
|
作者
Enlund-Cerullo, Maria [1 ,2 ,3 ,4 ]
Holmlund-Suila, Elisa [1 ,2 ,4 ]
Valkama, Saara [1 ,2 ,4 ]
Hauta-alus, Helena [1 ,2 ,4 ,5 ,6 ,7 ]
Rosendahl, Jenni [1 ,2 ,4 ]
Andersson, Sture [1 ,2 ]
Pekkinen, Minna [1 ,2 ,3 ,4 ]
Makitie, Outi [1 ,2 ,3 ,4 ,8 ,9 ]
机构
[1] Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland
[2] Helsinki Univ Hosp, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland
[3] Folkhalsan Inst Genet, Folkhalsan Res Ctr, Helsinki, Finland
[4] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland
[5] Natl Inst Hlth & Welf THL, Publ Hlth Res, Helsinki, Finland
[6] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland
[7] Univ Oulu, PEDEGO Res Unit, MRC Oulu, Oulu, Finland
[8] Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden
[9] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Clin Genet, Stockholm, Sweden
基金
瑞典研究理事会; 芬兰科学院;
关键词
FGF23; genetic variation; vitamin D; bone strength; infants (0-24 months); DOMINANT HYPOPHOSPHATEMIC RICKETS; PHYSIOLOGICAL-ROLE; MINERAL DENSITY; VITAMIN-D; PHOSPHATE; MUTATIONS; CHILDREN;
D O I
10.3389/fgene.2023.1192368
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: The effects of genetic variation in fibroblast growth factor 23 (FGF23) are unclear. This study explores the associations of single-nucleotide polymorphisms (SNPs) of FGF23 with phosphate and vitamin D metabolism and bone strength in early childhood. Methods: The study is part of the vitamin D intervention in infant (VIDI) trial (2013-2016), in which healthy term infants born to mothers of Northern European origin received vitamin D-3 supplementation of 10 or 30 mu g/day from 2 weeks to 24 months of age (ClinicalTrials.gov NCT01723852). Intact and C-terminal FGF23 (cFGF23), 25-hydroxyvitamin D (25-OHD), parathyroid hormone, phosphate, and peripheral quantitative computed tomography (pQCT)-derived bone strength parameters were analyzed at 12 and 24 months. The study included 622 VIDI participants with genotyping data on FGF23 SNPs rs7955866, rs11063112, and rs13312770. Results: Rs7955866 minor allele homozygotes had lowest cFGF23 at both time-points (mixed model for repeated measurements, p(variant) = 0.009). Minor alleles of rs11063112 were associated with a greater age-related decrease in phosphate concentration (p(interaction) = 0.038) from 12 to 24 months. Heterozygotes of rs13312770 had the greatest total bone mineral content (total BMC), cross-sectional area (total CSA), and polar moment of inertia (PMI) at 24 months (ANOVA p = 0.005, 0.037, and 0.036, respectively). Rs13312770 minor alleles were associated with a greater increase of total BMC, but a smaller increase of total CSA and PMI, during follow-up (p(interaction) <0.001, 0.043, and 0.012, respectively). Genotype of FGF23 did not modify 25-OHD. Conclusion: The study finds that genetic variation in FGF23 modifies cFGF23, phosphate, and pQCT-derived bone strength parameters from 12 to 24 months of age. These findings potentially promote an understanding of the regulation of FGF23 and its role in bone metabolism and temporal changes thereof during early childhood.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
    Feger, Martina
    Ewendt, Franz
    Strotmann, Joerg
    Schaeffler, Holger
    Kempe-Teufel, Daniela
    Glosse, Philipp
    Stangl, Gabriele I.
    Foeller, Michael
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (05): : 699 - 711
  • [22] Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients - Proposal of diagnostic criteria using FGF23 measurement
    Endo, Itsuro
    Fukumoto, Seiji
    Ozono, Keiichi
    Namba, Noriyuki
    Tanaka, Hiroyuki
    Inoue, Daisuke
    Minagawa, Masanori
    Sugimoto, Toshitsugu
    Yamauchi, Mika
    Michigami, Toshimi
    Matsumoto, Toshio
    BONE, 2008, 42 (06) : 1235 - 1239
  • [23] FGF23 and bone microarchitecture
    T. Rupp
    M. Amling
    T. Rolvien
    Osteoporosis International, 2019, 30 : 2359 - 2359
  • [24] FGF23 and bone microarchitecture
    Rupp, T.
    Amling, M.
    Rolvien, T.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (11) : 2359 - 2359
  • [25] The FGF23, a factor that rises
    Souberbielle, Jean-Claude
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2014, 18 (09): : 264 - 265
  • [26] Clinical Usefulness of Measurement of Fibroblast Growth Factor 23 (FGF23) in Hypophosphatemic Patients-Proposal of Diagnostic Criteria using FGF23 Measurement
    Endo, I.
    Fukumoto, S.
    Ozono, K.
    Namba, N.
    Tanaka, H.
    Inoue, D.
    Minagawa, M.
    Sugimoto, T.
    Yamauchi, M.
    Michigami, T.
    Matsumoto, T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S222 - S222
  • [27] Bone Metabolism and Fibroblast Growth Factor 23 (FGF23) after Pediatric Renal Transplantation (PRT)
    van Husen, M.
    Fischer, A. -K.
    Klaassen, I.
    Lehnhardt, A.
    Moeller, K.
    Kemper, M. J.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1910 - 1910
  • [28] Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly
    Chudek, Jerzy
    Kocelak, Piotr
    Owczarek, Aleksander
    Bozentowicz-Wikarek, Maria
    Mossakowska, Malgorzata
    Olszanecka-Glinianowicz, Magdalena
    Wiecek, Andrzej
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (09) : 1757 - 1763
  • [29] Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia
    Stefanopoulos, Dimitrios
    Nasiri-Ansari, Narjes
    Dontas, Ismene
    Vryonidou, Andromachi
    Galanos, Antonis
    Psaridi, Loukia
    Fatouros, Ioannis G.
    Mastorakos, George
    Papavassiliou, Athanasios G.
    Kassi, Eva
    Tournis, Symeon
    HORMONE AND METABOLIC RESEARCH, 2020, 52 (03) : 194 - 201
  • [30] Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
    Agoro, Rafiou
    Montagna, Anna
    Goetz, Regina
    Aligbe, Onyedikachi
    Singh, Gurinder
    Coe, Lindsay M.
    Mohammadi, Moosa
    Rivella, Stefano
    Sitara, Despina
    FASEB JOURNAL, 2018, 32 (07): : 3752 - 3764